Skip to main content
Premium Trial:

Request an Annual Quote

WHO Team Arrives

More than a dozen World Health Organization investigators have arrived in Wuhan, China, to begin their inquiry into the origins of SARS-CoV-2, NPR reports.

In December, the WHO announced it would be sending a team of between 12 and 15 investigators to Wuhan for about six weeks to collect samples from people and animals for testing. Experts suspect that the virus may have originated in bats and spent time in an intermediary animal before infecting people.

The WHO group ran into some problems this month when China prevented the team's entry. As NPR notes, China has been resistant to the idea that SARS-CoV-2 first infected people in Wuhan. But, according to NPR, the team now has the final approvals needed.

"The experts will begin their work immediately during the two weeks quarantine protocol for international travelers," the WHO says in a tweet. The New York Times notes that two members had to stay behind in Singapore following positive tests for SARS-CoV-2 antibodies.

The Times adds that the investigation, beginning more than a year after the first reported cases, will be "painstaking," as the team is expected to study those first cases, data from a market in Wuhan, and more, while navigating a thicket of political concerns.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.